Position in CHRS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$140,000
-$29,003 QoQ
Shares Held
100,000
-0.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 145 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names. CHRS ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
112,098 | $55,682,439 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,791 | $15,603,558 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,447 | $14,671,476 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
32,580 | $12,109,008 | |
| 5 | TECH |
BIO-TECHNE Corp
|
122,377 | $8,645,935 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,758 | $8,578,663 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,797 | $7,163,610 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
186,110 | $6,925,153 |
All Filings in CHRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,000 | 100,000 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $169,003 | 100,002 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $127,800 | 90,000 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $147,600 | 90,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,860 | 60,000 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $40,350 | 50,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $69,000 | 50,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $52,000 | 50,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $51,900 | 30,000 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||